Randox Pharma Services supplies a wide range of single analyte and multiplex diagnostic kits direct to end-user laboratories working within the translational science arena.
The sole purpose of translational science is to transfer scientific discoveries made in 'basic research' to clinical reality, to improve the health of individuals and reduce suffering Randox carries out research and development and custom assay development and supplies diagnostic solutions.
Even single analyte and multiplex diagnostic kits produced primarily for research come under the same scrutiny as any commercial IVD assay - in other words, imprecision less than 10 per cent, fully optimised to eliminate cross-reactivity and non-specific binding, to name a few of the company's stringent quality assurance processes.
Randox Pharma Services can be flexible and is quick to focus its in-house resources and expertise towards any pressing healthcare need, with a particular focus on oncology, infectious disease and metabolic disorders.
To enable this, Randox has developed Biochip Array Technology, a multiplex technology that allows the simultaneous detection of multiple biomarkers from a single patient sample.
Given the increased value of multiple biomarkers to improve patient diagnosis, such a technology is a suitable target platform for translational science.
Arrays have already been developed that are applicable to a range of therapeutic areas, with applications including multiplex immunoassays and nucleic acid-based SNP, mutation, gene expression and pathogen detection arrays.
Randox Pharma Services also offers more than 130 enzymatic, substrate and immunoturbidimetric assays on its range of RX series chemistry analysers.
